Stockscreener 앱 받기
8.56
3.38%
0.28
Treace Medical Concepts Inc 주식(TMCI)의 최신 뉴스
Brokerages Set Treace Medical Concepts, Inc. (NASDAQ:TMCI) Target Price at $7.40 - Defense World
TMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law Firm - GuruFocus.com
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Treace Announces Participation at Stifel 2024 Healthcare Conference - The Manila Times
Treace Medical CEO to Present at Stifel 2024 Healthcare Conference | TMCI Stock News - StockTitan
Treace Medical Concepts, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
ARMISTICE CAPITAL, LLC Acquires Significant Stake in Treace Medi - GuruFocus.com
Treace Medical Concepts Reports Strong Q3 2024 Growth - TipRanks
Morgan Stanley's Strategic Reduction in Treace Medical Concepts Inc. - GuruFocus.com
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: Treace Medical Concepts reported an 11% increase in third-quarter revenue - Investing.com India
U.S. Stock market: SONN(+86.46%), DataChat(+50.28%), Cytek Biosciences(+30.51%) among the top gainers during early trading - Business Upturn
Treace Medical (TMCI) Experiences Stock Boost After Reporting Strong Results - Stocks Telegraph
Treace Medical Concepts Inc (TMCI) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
TREACE ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Treace Medical Concepts (TMCI) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Treace Medical Concepts: Q3 Earnings Snapshot - San Francisco Chronicle
Treace Medical Concepts Reports Third Quarter 2024 Financial Results - The Manila Times
Vanguard Group Inc's Strategic Reduction in Treace Medical Conce - GuruFocus.com
Treace Announces Participation in the UBS Global Healthcare Conference - The Manila Times
Earnings Preview For Treace Medical Concepts - Benzinga
Treace Comments on CMS' 2025 Final Rule for Hospital Outpatient and ASC Settings - The Manila Times
Treace Comments on CMS’ 2025 Final Rule for Hospital Outpatient and ASC Settings - StockTitan
Treace Enters High Volume Osteotomy Market with Nanoplasty™ 3D Minimally Invasive Bunion Correction™ Procedure - The Manila Times
Treace Medical Concepts Inc (TMCI) Q3 2024 Earnings Report Preview: What To Look For - Yahoo Finance
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives $7.00 Consensus PT from Brokerages - Defense World
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of Investors - Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Treace Medical Concepts, Inc. (TMCI) on Behalf of Investors - Business Wire
Reviewing Treace Medical Concepts (NASDAQ:TMCI) & BrainsWay (NASDAQ:BWAY) - Defense World
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Treace Medical Concepts (TMCI) Set to Announce Quarterly Earnings on Tuesday - MarketBeat
TREACE ALERT: Bragar Eagel & Squire, P.C. is Investigating Treace Medical Concepts, Inc. on - The Bakersfield Californian
Is Treace Medical Concepts (NASDAQ:TMCI) Using Debt In A Risky Way? - Simply Wall St
SG Americas Securities LLC Purchases Shares of 23,591 Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
Bleakley Financial Group LLC Cuts Stock Position in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
Treace to Report Third Quarter 2024 Financial Results on November 5, 2024 - ForexTV.com
TMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law Firm - Benzinga
The Manufacturers Life Insurance Company Increases Position in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
Treace Files Patent Infringement and Unfair Competition Suit to Protect Lapiplasty® Bunion Technology - ForexTV.com
Truist Financial Lowers Treace Medical Concepts (NASDAQ:TMCI) Price Target to $6.00 - MarketBeat
Treace Files Patent Infringement and Unfair Competition Suit to Protect Lapiplasty® Bunion ... - Post Register
0.65%
자본화:
|
볼륨(24시간):